The Norton Lecture: A review of the oligodendrocyte in the multiple sclerosis lesion

Journal of Neuroimmunology

Volumn 77, Issue 2, 1997, Pages 135-152

  Raine, Cedric S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Autoimmunity; Immunology; Multiple sclerosis; Myelin; Oligodendrocyte

Indexed keywords

MYELIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; STAINING AND LABELING;

EID: 0030800188     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00073-8     Document Type: Review

References (113)

1. Abramsky, O., Lisak, R.P., Silberberg, D.H., Pleasure, D.E., 1977. Antibodies to oligodendroglia in patients with multiple sclerosis. New Eng. Med. J. 297, 1207-1281.
2. Appel, S.H., Bornstein, M.B., 1964. The application of tissue culture to the study of experimental 'allergic' encephalomyelitis. II. Serum factors responsible for demyelination. J. Exp. Med. 119, 303-312.
3. Aquino, D.A., Capello, E., Weisstein, J. Sanders, V., Lopez, C., Tourtellotte, W.W., Brosnan, C.F., Raine, C.S., Norton, W.T., 1997. Multiple sclerosis: Altered expression of 70- and 27kDa heat shock proteins in lesions and myelin. J. Neuropath. Exp. Neurol., in press.
4. Archer, D.R., Cuddon, P.A., Lipsitz, D., Duncan, I.D., 1997. Myelination of the canine central nervous system by glial cell transplantation: A model for repair of human myelin disease. Nature Med. 3, 54-59.
5. Armstrong, R.C., Dorn, H.H., Kufta, C.V., Friedman, E., Dubois-Dalcq, M.B., 1992. Pre-oligodendrocytes from adult human CNS. J. Neurosci. 12, 1538-1547.
6. Asai, T., Wanaka, A., Kato, H., Masana, Y., Seo, M., Tohyama, M., 1995. Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system. Mol. Brain Res. 17, 174-178.
7. Barres, B.A., Schmid, R., Sendnter, M., Raff, M.C., 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
8. Barres, B.A., Raff, M.C., Gaese, F., Bartke, L., Dechant, G., Barde, V.A., 1994. A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367, 371-375.
9. Beutler, B., van Huffel, C., 1994. Unraveling function in the TNF ligand and receptor families. Science 264, 667-668.
10. Bonetti, B., Raine, C.S., 1997. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol., in press.
11. Born, W., Happ, M.P., Dallas, A., 1990. Recognition of heat shock proteins and γδ cell function. Immunol. Today 11, 40-43.
12. Bornstein, M.B., Appel, S.H., 1961. The application of tissue culture to the study of experimental 'allergic' encephalomyelitis. I. Patterns of demyelination. J. Neuropath. Exp. Neurol. 20, 141-157.
13. Bornstein, M.B., Raine, C.S., 1970. Experimental allergic encephalomyelitis: Antiserum inhibition of myelination in vitro. Lab. Invest. 23, 536-542.
14. Bornstein, M.B., Raine, C.S., 1977. Multiple sclerosis and experimental allergic encephalomyelitis: Specific demyelination in vitro. Neuropath. Appl. Neurobiol. 3, 359-369.
15. Brosnan, C.F., Raine, C.S., 1996. Mechanisms of immune injury in multiple sclerosis. Brain Path. 6, 243-257.
16. Brosnan, C.F., Traugott, U., Raine, C.S., 1983. Analysis of humoral and cellular events and the role of lipid haptens during CNS demyelination. Acta Neuropath. (Berlin) Supp. 9, 59-70.
17. Bunge, R.P., Bunge, M.B., Ris, H., 1960. Electron microscopic study of demyelination in an experimentally induced lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 7, 685-696.
18. Bunge, M.B., Bunge, R.P., Ris, H., 1961. Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J. Biophys. Biochem. Cytol. 10, 67-94.
19. Bunge, M.B., Bunge, R.P., Pappas, G.D., 1962. Electron microscope demonstration of connections between glia and myelin sheaths in the developing mammalian C.N.S. J. Biophys. Biochem. Cytol. 12, 448-453.
20. Cannella, B., Raine, C.S., 1995. The adhesion molecule/cytokine profile of multiple sclerosis lesions. Ann. Neurol. 27, 424-435.
21. Capello, E., Voskuhl, R.R., McFarland, H.F., Raine, C.S., 1997. Multiple sclerosis: Implications of re-expression of a developmental gene (X2 MBP) for repair of chronic lesions. Ann. Neurol., in press.
22. Casaccia-Bonnefil, P., Carter, B.D., Dobrowski, R.T., Chao, M.V., 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716-719.
23. D'Souza, S., Alinauskas, K., McRea, E., Goodyer, C., Antel, J.P., 1995. Differential susceptibility of human CNS derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15, 7293-7300.
24. D'Souza, S.D., Bonetti, B., Balasingam, V., Cashman, N.R., Barker, P.A., Troutt, A.B., Raine, C.S., Antel, J.P., 1996. Multiple sclerosis: Fas signaling in oligodendrocyte death. J. Exp. Med. 184, 2361-2370.
25. del Rio-Hortega, P., 1921. La glia de escasas radiaciones (oligodendroglia). Bulletin de la Real Sociedad Espanola di Historie Natural 21, 63-92.
26. Dowling, P., Shang, G., Raval, S., Menonna, J., Cook, S., Husar, W., 1996. Involvement of the CD95 (APO-1, Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184, 1513-1518.
27. Epstein, L.G., Prineas, J.W., Raine, C.S., 1983. Attachment of myelin to coated pits on macrophages in experimental allergic encephalomyelitis. J. Neurol. Sci. 61, 341-348.
28. Franklin, R.J.M., 1993. Reconstructing myelin deficient environments in the CNS by glial cell transplantation. Neuroscience 5, 443-452.
29. Freedman, M.S., Ruijs, T.C.G., Selin, S.K., Antel, J.P., 1991. Peripheral blood γδ T cells lyse fresh human brain-derived oligodendrocytes. Ann. Neurol. 30, 794-800.
30. Freedman, M.S., Buu, N.N., Fuijs, T.C.G., Williams, K., Antel, J.P., 1992. Differential expression of heat shock proteins by human glial cells. J. Neuroimmunol. 41, 231-238.
31. + oligodendrocyte progenitors. Dev. Biol. 159, 618-639.
32. Gavrieli, Y., Sherman, Y., Ben-Sasson, S.A., 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493-501.
33. Genain, C.P., Roberts, T., Davis, R.L., Nguyen, M.H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J., Hauser, S.L., 1995. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92, 3601-3605.
34. Genain, C.P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D.P., Linington, C., Raine, C.S., Hauser, S.L., 1996. Late complications of immune deviation therapy in a non-human primate. Science 274, 2054-2057.
35. Ghatak, N.K., 1992. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions. J. Neuropath. Exp. Neurol. 51, 40-46.
36. Ghatak, N.K., Leshner, R.T., Price, A.C., Felton, W.L., 1989. Remyelination in the human central nervous system. J. Neuropath. Exp. Neurol. 48, 507-518.
37. Gogate, N., Verma, L., Zhou, J.M., Milward, E., Rusten, R., O'Connor, M., Kufta, C., Kim, J., Hudson, L., Dubois-Dalcq, M., 1994. Plasticity in the adult human oligodendrocyte lineage. J. Neurosci. 14, 4571-4587.
38. Grinspan, J.B., Stera, J., Franceschini, B., Yasuda, T., Pleasure, D., 1994. Protein growth factors as potential therapies for central nervous system demyelinative disorders. Ann. Neurol. 36, S140-S142.
39. Hardesty, I., 1905. On the occurrence of sheath cells and the nature of the axone sheaths in the central nervous system. Am. J. Anat. 4, 329-354.
40. Holoshitz, J., 1990. Potential role of γδ T cells in autoimmune disease. Res. Immunol. 141, 651-657.
41. Jordan, C., Friedrich, V., Dubois-Dalcq, M., 1989. In situ hybridization analysis of myelin gene transcripts in developing mouse spinal cord. J. Neurosci. 9, 248-257.
42. Kaufmann, S.H., 1994. Heat shock proteins and autoimmunity: a critical appraisal. Int. Arch. All. Immunol. 130, 317-322.
43. Kerr, J.F.R., Wylie, A.H., Currie, A.R., 1972. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer. 26, 239-257.
44. Kim, S.U., 1985. Antigen expression by glial cells grown in culture. J. Neuroimmunol. 8, 255-282.
45. Lee, S.C., Raine, C.S., 1989. Multiple sclerosis: Oligodendrocytes do not express class II major histocompatibility molecules in active lesions. J. Neuroimmunol. 25, 261-266.
46. Lee, S.C., Moore, G.R.W., Golenwsky, G., Raine, C.S., 1990. A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J. Neuropath. Exp. Neurol 49, 122-136.
47. Liedtke, W., Edelmann, W., Bieri, P.L., Chiu, F.-C., Cowan, N., Kucherlapati, R., Raine, C.S., 1996. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17, 607-615.
48. Linington, C., Engelhardt, B., Kapos, G., Lassmann, H., 1992. Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J. Neuroimmunol. 40, 219-224.
49. Liu, X., Yao, D.-L., Webster, H.F. De, 1994. Astrocytes express insulin-like growth factor-1 (IGF-1) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol. Cell. Neurosci. 5, 418-430.
50. Lucchinetti, C.F., Brück, W., Rodriguez, M., Lassmann, H., 1996. Distinct patterns of multiple sclerosis pathology indicates heterogeneity of pathogenesis. Brain Path. 6, 259-274.
51. Lumsden, C.E., 1955. The neuropathology of multiple sclerosis. In: McAlpine, D., Compston, N.D., Lumsden, C.E. (Eds.), Multiple Sclerosis. Livingstone, Edinburgh, p. 231.
52. Lumsden, C.E., 1970. The neuropathology of multiple sclerosis. In: Vinken P.J., Bruyn G.W. (Eds.), Handbook of Clinical Neurology, Vol. 9. North-Holland Publishing Co., Amsterdam, pp. 217-309.
53. Massacesi, L., Genain, C.P., Lee-Parritz, D., Letvin, N., Canfield, D., Hauser, S.L., 1995. Actively and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann. Neurol. 37, 519-530.
54. McKinnon, R.D., Smith, C., Behar, T., Smith, T., Dubois-Dalcq, M., 1993. Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells. Glia 7, 245-254.
55. Moore, G.R.W., Raine, C.S., 1988. Immunogold localization and analysis of IgG in acute experimental allergic encephalomyelitis. Lab. Invest. 59, 641-648.
56. Moore, G.R.W., Traugott, U., Farooq, M., Norton, W.T., Raine, C.S., 1984. Experimental autoimmune encephalomyelitis: Augmentation of demyelination by different myelin lipids. Lab. Invest. 51, 424-516.
57. Muir, D.A., Compston, D.A.S., 1996. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J. Neurosci. Res. 44, 1-11.
58. Norton, W.T., Farooq, M., 1990. Bulk isolation and culture of oligodendroglia from mature brain. In: P.M. Conn (Ed.), Methods in Neurosciences. Academic Press, New York, pp. 171-178.
59. Norton, W.T., Farooq, M., Fields, K.L., Raine, C.S., 1983. The long term culture of bulk-isolated bovine oligodendroglia from adult brain. Brain Res. 270, 295-310.
60. Oger, J., Szuchet, S., Antel, J., Arnason, B.G.W., 1982. A monoclonal antibody against human T suppressor lymphocytes binds specifically to the surface of cultured oligodendrocytes. Nature 295, 66-68.
61. Penfield, W., 1932. Neuroglia: Normal and pathological, In: Cytology and Cellular Pathology of the Nervous Tissue, Vol. II. Hoeber, New York, pp. 421-480.
62. Périer, O., Grégoire, A., 1965. Electron microscopic features of multiple sclerosis lesions. Brain 88, 937-952.
63. Peters, A., Proskauer, C.C., 1969. The ratio between myelin segments and oligodendrocytes in the optic nerve of the adult rat. Anat. Rec. 163, 243A.
64. Peterson, E.R., Murray, M.R., 1955. Myelin sheath formation in cultures of avian spinal ganglia. Am. J. Anat. 96, 319-355.
65. Prineas, J., 1985. The neuropathology multiple sclerosis. In: J.C. Koetsier (Ed.), Handbook of Clinical Neurology, Demyelinating Diseases, 3(47). Elsevier Pub. Co., Amsterdam, pp. 213-257.
66. Prineas, J.W., Connell, F., 1978. The fine structure of chronically active multiple sclerosis plaques. Neurology 28, 68-75.
67. Prineas, J.W., Connell, F., 1979. Remyelination in multiple sclerosis. Ann. Neurol. 5, 22-31.
68. Prineas, J.W., Graham, J.S., 1981. Multiple sclerosis: Capping of surface immunoglobulin G on macrophages in myelin breakdown. Ann. Neurol. 10, 149-158.
69. Prineas, J.W., Raine, C.S., 1976. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology 26, 29-32.
70. Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Ilyas, A.A., Quarles, R.H., Benjamins, J.A., Sprinkle, T.J., 1989. Multiple sclerosis: Oligodendrocyte proliferation and differentiation in fresh lesions. Lab. Invest. 61, 489-503.
71. Prineas, J.W., Kwon, E.E., Goldenberg, P.Z., Cho, E.S., Sharer, L.R., 1990. Interaction of astrocytes and newly formed oligodendrocyte in resolving multiple sclerosis lesions. Lab. Invest. 63, 624-636.
72. Prineas, J.W., Barnard, R.P., Kwon, E.E., Sharer, L.R., Cho, E.S., 1993. Multiple sclerosis: Remyelination of nascent lesions. Ann. Neurol. 33, 137-151.
73. Raine, C.S., 1984. Biology of Disease. The analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab. Invest. 50, 608-635.
74. Raine, C.S., 1991. Multiple Sclerosis: A pivotal role for the T cell in lesion development. Neuropath. Appl. Neurobiol. 17, 265-274.
75. Raine, C.S., 1994. The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion. Ann. Neurol. 36, S61-72.
76. Raine, C.S., 1995. Multiple sclerosis: TNF revisited, with promise. Nature Med. 1, 211-214.
77. Raine, C.S., 1997a. Demyelinating diseases. In: Davis, R.L., Robertson, D.M. (Eds.), Textbook of Neuropathology (Third Edition). Williams and Williams, Baltimore, pp. 243-287.
78. Raine, C.S., 1997b. The neuropathology of multiple sclerosis. In: Raine, C.S., McFarland H.F., Tourtellotte, W.W. (Eds)., Multiple Sclerosis: Clinical and Pathogenetic Basis. Chapman and Hall, London, pp. 151-171.
79. Raine, C.S., 1997c. The lesion in multiple sclerosis and chronic relapsing experimental allergic encephalomyelitis, a structural comparison. In: Raine, C.S., McFarland, H.F., Tourtellotte, W.W. (Eds), Multiple Sclerosis: Clinical and Pathogenetic Basis. Chapman and Hall, London, pp. 243-285.
80. Raine, C.S., Bornstein, M.B., 1970a. Experimental allergic encephalomyelitis. An ultrastructural study of experimental demyelination in vitro. J. Neuropath. Exp. Neurol. 29, 177-191.
81. Raine, C.S., Bornstein, M.B., 1970b. Experimental allergic encephalomyelitis: A light and electron microscope study of remyelination and sclerosis in vitro. J. Neuropath. Exp. Neurol. 29, 552-574.
82. Raine, C.S., Scheinberg, L.C., 1988. On the immunopathology of plaque development and repair in multiple sclerosis. J. Neuroimmunol. 20, 189-201.
83. Raine, C.S., Traugott, U., 1983. Chronic relapsing autoimmune encephalomyelitis: Ultrastructure of the CNS of animals treated with combinations of myelin components. Lab. Invest. 48, 275-284.
84. Raine, C.S., Traugott, U., 1984. Experimental autoimmune demyelination: Chronic relapsing models and their therapeutic implications for multiple sclerosis. In: Multiple Sclerosis: Experimental and clinical aspects. L.C. Scheinberg and C S. Raine (Eds.). Ann. N.Y. Acad. Sci. 436, 33-51.
85. Raine, C.S., Wu, E., 1993. Multiple sclerosis: Remyelination in acute lesions. J. Neuropath. Exp. Neurol. 52, 199-205.
86. Raine, C.S., Hummelgard, A., Swanson, E., Bornstein, M.B., 1973. Multiple Sclerosis: Serum-induced demyelination in vitro. A light and electron microscope study. J. Neurol. Sci. 20, 127-148.
87. Raine, C.S., Johnson, A.B., Marcus, D., Suzuki, A., Bornstein, M.B., 1981a. Demyelination in vitro: Absorption studies demonstrate that galactocerebroside is a major target. J. Neurol. Sci. 52, 117-131.
88. Raine, C.S., Scheinberg, L.C., Waltz, J.M., 1981b. Multiple sclerosis: Oligodendrocyte survival and proliferation in an active, established lesion. Lab. Invest. 45, 534-546.
89. Raine, C.S., Traugott, U., Farooq, M., Bornstein, M.B., Norton, W.T., 1981c. Augmentation of immune-mediated demyelination by lipid haptens. Lab. Invest. 45, 174-182.
90. Raine, C.S., Wu, E., Brosnan, C.F., 1994. The immunologic response of the oligodendrocyte in the active multiple sclerosis lesion. In: S. Salvati (Ed.), A Multidisciplinary Approach to Myelin Disease. Plenum, New York, pp. 143-151.
91. Raine, C.S., Wu, E., Ivanyi, J., Katz, D., Brosnan, C.F., 1996. Multiple sclerosis: A protective or a pathogenic role for heat-shock protein 60 in the central nervous system?. Lab. Invest. 75, 109-123.
92. Robertson, W.F., 1899. On the new method of obtaining a black reaction in certain tissue elements of the central nervous system (Platinum Method). Scot. Med. Surg. 4, 23-30.
93. Satoh, J., Nomaguchi, H., Tabira, T., 1992a. Constitutive expression of 65 kDa heat shock protein (Hsp 65)-like immunoreactivity in cultured mouse oligodendrocytes. Brain Res. 595, 281-290.
94. Satoh, J., Yamamura, T., Kunishita, T., Tabira, T., 1992b. Heterogeneous induction of a 72 kDa heat shock protein (HSP72) in cultured mouse oligodendrocytes and astrocytes. Brain Res. 573, 37-43.
95. Selmaj, K., Raine, C.S., 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23, 339-346.
96. Selmaj, K., Farooq, M., Norton, W.T., Raine, C.S., Brosnan, C.F., 1990. Proliferation of astrocytes in vitro in response to cytokines. A primary role of tumor necrosis factor. J. Immunol. 144, 129-135.
97. Selmaj, K., Brosnan, C.F., Raine, C.S., 1991a. Colocalization of TCR γδ lymphocytes and hsp-65+ oligodendrocytes in multiple sclerosis. Proc. Natl. Acad. Sci. USA 88, 6452-6456.
98. Selmaj, K., Raine, C.S., Cannella, B., Brosnan, C.F., 1991b. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87, 949-954.
99. Selmaj, K., Raine, C.S., Farooq, M., Norton, W.T., Brosnan, C.F., 1991c. Cytokine cytotoxicity against oligodendrocytes: Apoptosis induced by lymphotoxin. J. Immunol. 147, 1522-1529.
100. Selmaj, K., Shafit-Zagardo, B., Farooq, M., Aquino, D., Norton, W.T., Raine, C.S., Brosnan, C.F., 1991d. TNF-induced proliferation of astrocytes from mature brain is associated with down-regulation of GFAP mRNA. J. Neurochem. 57, 823-828.
101. Selmaj, K., Brosnan, C.F., Raine, C.S., 1992. Expression of heat shock protein-65 by oligodendrocytes in vivo and in vitro: Implications for multiple sclerosis. Neurology 42, 795-800.
102. Shinar, Y., McMorris, F.A., 1995. Developing oligodendroglia express mRNA for insulin-like growth factor-1, a regulator of oligodendrocyte development. J. Neurosci. Res. 42, 516-527.
103. Suzuki, K., Andrews, J.M., Waltz, J.M., Terry, R.D., 1969. Ultrastructural studies of multiple sclerosis. Lab. Invest. 20, 444-454.
104. Suzumura, A., Silberberg, D.H., Lisak, R.P., 1986. The expression of MHC antigens on oligodendrocytes: Induction of polymorphic H-2 expression by lymphokines. J. Neuroimmunol. 11, 179-190.
105. Traugott, U., Snyder, D.S., Raine, C.S., 1979. Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann. Neurol. 6, 13-20.
106. Van Noort, J.M., van Sechel, A.C., Bajramoric, J.J., el Ouagmiri, M., Polman, Lassman, H., Ravid, R., 1995. The small heat shock protein alpha-B crystallin as a candidate autoantigen in multiple sclerosis. Nature 375, 798-801.
107. Vartanian, T., Li, Y., Zhao, M., Stefansson, K., 1995. Interferon-gamma induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol. Med. 1, 732-743.
108. Vassalli, P., 1992. The pathophysiology of tumor necrosis factor. Ann. Rev. Immunol. 10, 411-452.
109. Vignais, L., Nait-Oumesmar, B., Mellouk, F., Gout, O., Labourdette, G., Baron-Van Evercooren, A., Gumpel, M., 1993. Transplantation of oligodendrocyte precursors in the adult demyelinated spinal cord: Migration and remyelination. Int. J. Dev. Neurosci. 11, 603-612.
110. Williams, K.C., Ulvestad, E., Hickey, W.F., 1994. Immunology of multiple sclerosis. Clin. Neurosci. 2, 229-245.
111. Wilt, S.G., Milward, E., Zhou, J.M., Nagasato, K., Patton, H., Rusten, R., Griffin, D.E., O'Connor, M., Dubois-Dalcq, M., 1995. In vitro evidence for a dual role for tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37, 381-394.
112. Wu, E., Raine, C.S., 1992. Multiple sclerosis: Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non-demyelinating conditions. Lab. Invest. 67, 88-99.
113. Young, R.A., 1990. Stress proteins and immunology. Ann. Rev. Immunol. 8, 401-420.